Cardiovasular
Diabetes/Cardiovascular
Acurian Keeps Enrollment on Track and Saves Over $12 Million for a Sponsor of a Global Diabetes CV Outcomes Study
This seven-year outcomes study is critical to the success of a compound that is expected to build on the sponsor’s
leadership position in diabetes care.